Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugammadex vs Neostigmine in Supratentorial Brain Tumor Surgery
NCT02944175Unknown
- Sponsor
- Mansoura University
- Start
- Jul 2016
- Primary completion
- Sep 2019
- Modality
- Biodegradable Polymers, Small Molecules
01
Overview
Randomised trial of Sugammadex in neuromuscular blockade (NMB), sponsored by Mansoura University. Primary endpoint: Time to recovery of the train-of-four ratio to 0.9 at 1 hour. Status: unknown.
02
Drugs
Sugammadex
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT02944175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02944175.